Advanced search
Publication Cover
Pediatric Hematology and Oncology Volume 25, 2008 - Issue 5
Submit an article Journal homepage
117
Views
10
CrossRef citations to date
0
Altmetric
Case Report

A CASE SERIES OF CHILDREN WITH HIGH-RISK METASTATIC NEUROBLASTOMA TREATED WITH A NOVEL TREATMENT STRATEGY CONSISTING OF POSTPONED PRIMARY SURGERY UNTIL THE END OF SYSTEMIC CHEMOTHERAPY INCLUDING HIGH-DOSE CHEMOTHERAPY

Yoshiko Hashii Departments of Pediatrics and Pediatric Surgery, Osaka University Graduate School of Medicine, Osaka, Japan
, MD, PhD,
Takeshi Kusafuka Departments of Pediatrics and Pediatric Surgery, Osaka University Graduate School of Medicine, Osaka, Japan
, MD, PhD,
Hideaki Ohta Departments of Pediatrics and Pediatric Surgery, Osaka University Graduate School of Medicine, Osaka, Japan
, MD, PhD,
Akihiro Yoneda Departments of Pediatrics and Pediatric Surgery, Osaka University Graduate School of Medicine, Osaka, Japan
, MD, PhD,
Yuko Osugi Departments of Pediatrics and Pediatric Surgery, Osaka University Graduate School of Medicine, Osaka, Japan
, MD, PhD,
Yasutsugu Kobayashi Department of Pathology, Osaka City General Hospital, Osaka, Japan
, MD, PhD,
Masahiro Fukuzawa Departments of Pediatrics and Pediatric Surgery, Osaka University Graduate School of Medicine, Osaka, Japan
, MD, PhD, &
Junichi Hara Departments of Pediatrics and Pediatric Surgery, Osaka University Graduate School of Medicine, Osaka, Japan
, MD, PhD show all
Pages 439-450 | Received 16 Apr 2007, Accepted 19 Mar 2008, Published online: 09 Jul 2009

REFERENCES

  • Berthold F, Hero B, Kremens B, et al. Long-term results and risk profiles of patients in five consecutive trials (1979–1997) with stage 4 neuroblastoma over 1 year of age. Cancer Lett. 2003; 197(1–2)11–17
  • Brodeur GM, Maris JM. Neuroblastoma. Lippincott Williams & Wilkins, Philadelphia 2006; 933–970
  • Matthay KK, Villablanca JG, Seeger RC, et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med. 1999; 341: 1165–1173
  • Stram DO, Matthay KK, O’Leary M, et al. Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children's Cancer Group studies. J Clin Oncol. 1996; 14: 2417–2426
  • Berthold F, Boos J, Burdach S, et al. Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial. Lancet Oncol. 2005; 6: 649–658
  • Castel V, Tovar JA, Costa E, et al. The role of surgery in stage IV neuroblastoma. J Pediatr Surg. 2002; 37: 1574–1578
  • Kaneko M, Ohakawa H, Iwakawa M. Is extensive surgery required for treatment of advanced neuroblastoma?. J Pediatr Surg. 1997; 32: 1616–1619
  • Kushner BH, Wolden S, LaQuaglia MP, et al. Hyperfractionated low-dose radiotherapy for high-risk neuroblastoma after intensive chemotherapy and surgery. J Clin Oncol. 2001; 19: 2821–2828
  • Haas-Kogan DA, Swift PS, Selch M, et al. Impact of radiotherapy for high-risk neuroblastoma: a Children's Cancer Group study. Int J Radiat Oncol Biol Phys. 2003; 56: 28–39
  • Bradfield SM, Douglas JG, Hawkins DS, et al. Fractionated low-dose radiotherapy after myeloablative stem cell transplantation for local control in patients with high-risk neuroblastoma. Cancer 2004; 100: 1268–1275
  • Mugishima H, Matsunaga T, Yagi K, et al. Phase I study of irinotecan in pediatric patients with malignant solid tumors. J Pediatr Hematol Oncol. 2002; 24: 94–100
  • Hara J, Osugi Y, Ohta H, et al. Double-conditioning regimens consisting of thiotepa, melphalan and busulfan with stem cell rescue for the treatment of pediatric solid tumors. Bone Marrow Transplant. 1998; 22: 7–12
  • The Committee of Histological Classification of Childhood Tumors. Histrological Classfication and Color Atlas of Tumors inInfancy and Childhood: Peripheral Neuroblastic Tumors and Phenochromocytoma. Kanehara, Tokyo 2004; 34–35
  • Kletzel M, Abella EM, Sandler ES, et al. Thiotepa and cyclophosphamide with stem cell rescue for consolidation therapy for children with high-risk neuroblastoma: a phase I/II study of the Pediatric Blood and Marrow Transplant Consortium. J Pediatr Hematol Oncol. 1998; 20: 49–54
  • Pinkerton CR. ENSG 1-randomised study of high-dose melphalan in neuroblastoma. Bone Marrow Transplant. 1991; 7(Suppl 3)112–113

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.